Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 2, 2006, Pages 260-265

  Baranska Rybak W ^a,b   Sonesson, A ^b   Nowicki, R ^a   Schmidtchen, A ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Department of Clinical Sciences   (Sweden)

Author keywords

Antibacterial peptides; Bacteria; Plasma; Serum; Wound fluids

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHITOSAN; CITRIC ACID; DIETHYLAMINOETHYLDEXTRAN; GLYCOSAMINOGLYCAN; HEPARIN; POLYCATION; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOASSAY; BLOOD ANALYSIS; BODY FLUID; CONTROLLED STUDY; CORRELATION ANALYSIS; ESCHERICHIA COLI; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STAPHYLOCOCCUS AUREUS; WOUND FLUID;

ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; ANTIMICROBIAL CATIONIC PEPTIDES; BODY FLUIDS; ESCHERICHIA COLI; GLYCOSAMINOGLYCANS; HEPARIN; MICROBIAL SENSITIVITY TESTS; PLASMA; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; WOUNDS AND INJURIES;

EID: 31544463056     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki460     Document Type: Article

References (22)

1. Sörensen OE, Follin P, Johnsen AH et al. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 2001; 97: 3951-9.
2. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004; 75: 39-48.
3. Agerberth B, Charo J, Werr J et al. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96: 3086-93.
4. Malm J, Sörensen O, Persson T et al. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect Immun 2000; 68: 4297-302.
5. Bals R, Wang X, Wu Z et al. Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998; 102: 874-80.
6. Frohm M, Agerberth B, Ahangari G et al. The expression of the gene coding for antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997; 24: 15258-63.
7. Nizet V, Ohtake T, Lauth X et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414: 454-7.
8. Wang Y, Agerberth B, Lothgren A et al. Apolipoprotein A-I binds and inhibits antibacterial/cytotoxic peptide LL-37. J Biol Chem 1998; 273: 33115-8.
9. Johansson J, Gudmundsson GH, Rottenberg ME et al. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 1998; 273: 3718-24.
10. Schmidtchen A, Frick IM, Andersson E et al. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 2002; 46: 157-68.
11. Andersson E, Rydengård V, Sonesson A et al. Antimicrobial activities of heparin-binding peptides. Eur J Biochem 2004; 271: 1219-26.
12. Penc SF, Pomahac B, Winkler T et al. Dermatan sulphate released after injury is a potent promoter of fibroblast growth factor-2 function. J Biol Chem 1998; 273: 28116-21.
13. Masny A, Pfucienniczak A. Fingerprinting of bacterial genomes by amplification of DNA fragments surrounding rare restriction sites. BioTechniques 2001; 31: 930-36.
14. Lehrer RI, Rosenman M, Harwig SS et al. Ultrasensitive assays for endogenous antimicrobial polypeptides. J Immunol Methods 1991; 137: 167-73.
15. Björnsson S. Quantitation of proteoglycans as glycosaminoglycans in biological fluids using an alcian blue dot blot analysis. Anal Biochem 1998; 256: 229-37.
16. Berlau J, Lorenz P, Beck R et al. Analysis of aqueous humour proteins of eyes with and without pseudoexfoliation syndrome. Graefes Arch Clin Exp Opthalmol 2001; 239: 743-6.
17. Schmidtchen A, Frick IM, Björck L. Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial α-defensin. Mol Microbiol 2001; 39: 708-13.
18. Schmidtchen A. Chronic ulcers: A method for sampling and analysis of wound fluid. Acta Derm Venereol 1999; 79: 291-295.
19. Capila I, Linhardt RJ. Heparin-protein interactions. Angew Chem Int Ed Engl 2002; 41: 390-412.
20. Ågren MS, Eaglstein WH, Ferguson MW et al. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol Suppl (Stockh) 2000; 210: 3-17.
21. Davies CE, Wilson MJ, Hill KE et al. Use of molecular techniques to study microbial diversity in the skin: Chronic wounds reevaluated. Wound Repair Regen 2001; 9: 332-40.
22. Schmidtchen A, Holst E, Tapper H et al. Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth. Microb Pathogen 2003; 34: 47-55.